Novavax COVID Vaccine Efficacy In Omicron, Delta Variants Among Unknowns Ahead Of Advisory Cmte

US FDA also says there appears to be 'causal association' of myocarditis with the vaccine, which Novavax denies.

Novavax vaccine
The FDA's Vaccines and Related Biological Products Advisory Committee will meet 7 June to discuss the Novavax COVID-19 vaccine EUA request. • Source: Shutterstock

Novavax, Inc.’s proposed COVID-19 vaccine showed strong efficacy against older variants, but the US Food and Drug Administration now wonders how it will perform against the current virus strain.

The company is seeking an emergency use authorization for a two-dose primary series of its adjuvanted recombinant spike protein

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Vaccines

More from Pink Sheet

Inclusive By Design: UK Pilots Diversity Plans For Drug & Device Trials

 
• By 

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

UK’s International Recognition Procedure: EU Dossier Faster Than US Or Canada

 

Companies that use the European Medicines Agency as a reference regulator for the UK’s International Recognition Procedure can expect a faster approval than those that use other national regulators, such as those in the US and Canada, an MHRA spokesperson has said.

FDA Use Of Artificial Intelligence Will Help US Retain Biotech Leadership

 

At a House subcommittee hearing, HHS Secretary Robert F. Kennedy Jr. rebutted lawmaker concerns that NIH cuts will drive research and scientists to other countries and said he does not want to advise parents on vaccinating children for measles, chickenpox or polio.